Atorvastatin Calcium Hydrate/Amlodipine/Perindopril Arginine

阿托伐他汀钙水合物/氨氯地平/培哚普利

Report date: 2025/07/25 10:36:07

Base Information

Drug NameAtorvastatin Calcium Hydrate/Amlodipine/Perindopril Arginine
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsHMG-CoA reductase inhibitorsVoltage-gated calcium channel blockers
TargetsAngiotensin-converting enzymeHMG-CoA reductaseVoltage-gated calcium channel
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Atorvastatin Calcium HydrateAmlodipine/Perindopril Arginine
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires Servier
Inactive CompaniesLes Laboratoires Servier IndustrieLes Laboratoires ServierServier (Tianjin) Pharmaceutical Co Ltd
Active IndicationsHypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A